Latest filing published 29 Feb 2008 for Interpace Biosciences, INC., €66k.
Insider track record
No signal scores available.
Kevin Connolly: trading record in brief
All filings by Kevin Connolly on record concern Interpace Biosciences, Inc. Between 15 February 2006 and 27 February 2008, the trades on record add up to 4 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
Most recently, on 29 February 2008, the filings show a share grant worth €66k in Interpace Biosciences, Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Kevin Connolly
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 12,937 shares@ US$7.73Common StockSEC:0001140361-08-005488:0
- 10,504 shares@ US$9.52Common StockSEC:0001140361-07-006972:0
- 8,000 shares@ US$11.63Common StockSEC:0001054102-06-000063:0
3 of 3 declarations